Key result
Interleukin-17 exerts dual, controversial effects on atherosclerotic plaque stability and acute coronary syndrome onset.
Answers are grounded in this paper and cite their sources.
Review summarizes the dual functions of interleukin-17 in acute coronary syndrome, suggesting complex regulatory roles in atherosclerotic plaque stability.
Inflammation plays an important role in atherosclerosis, which is also crucial for acute coronary syndrome (ACS). Recent studies have revealed that interleukin (IL)-17, which was regarded as a pro-inflammatory cytokine, has a dual function in the progress of ACS. In this review, we sum up both experimental and clinical studies on the relevance of IL-17 to atherosclerosis and its complications, and summarize the research progress on the effect of IL-17 on the atherosclerotic plaque stability and ACS onset. Although the studies are controversial and the mechanism remains unclear, we highlight the knowledge of the role of IL-17 in ACS and elucidate its potential mechanism.
No takes yet. Share an insight, caveat, or question.
Su et al. (2013) conducted a review in Acute coronary syndrome and atherosclerosis. Interleukin-17 (IL-17) was evaluated on Atherosclerotic plaque stability and acute coronary syndrome onset. Interleukin-17 plays a dual and controversial role in atherosclerotic plaque stability and acute coronary syndrome onset (no quantitative effect reported).
Synapse has enriched 10 related papers. Consider them for comparative context: